Insiders · SUPN

John M Siebert

Director at Supernus Pharmaceuticals, Inc. (SUPN)

John M Siebert has filed 8 insider reports with the SEC since February 2021, as director at Supernus Pharmaceuticals, Inc. (SUPN). The latest filing, on February 27, 2024, reports grant or award and sale back to the company at Supernus Pharmaceuticals, Inc. (SUPN).

Filings
8
Companies
1
Bought on market
None
Sold on market
None

Companies where John M Siebert is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Supernus Pharmaceuticals, Inc. logo
SUPN
Supernus Pharmaceuticals, Inc.
Director87,943$28.96Feb 27, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare John M Siebert with

Other insiders at the same companies

Questions about John M Siebert

What is John M Siebert's role at Supernus Pharmaceuticals, Inc.?
John M Siebert reports to the SEC as director at Supernus Pharmaceuticals, Inc. (SUPN), according to the latest filing on February 27, 2024.
How many shares does John M Siebert own?
After the latest filing that states it, John M Siebert directly owned 87,943 shares of Supernus Pharmaceuticals, Inc. (SUPN). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has John M Siebert bought or sold stock recently?
No open-market purchases or sales by John M Siebert are on file. The filings report grant or award, sale back to the company and exercise or conversion of a derivative.
How do I get alerts when John M Siebert files?
Follow John M Siebert on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by John M Siebert (SEC CIK 0001190558). Totals count each trade once, skipping amendments whose original is on file, from Feb 23, 2021 on. View on SEC EDGAR